
SKWD Stock Forecast & Price Target
SKWD Analyst Ratings
Bulls say
Skyward Specialty is viewed favorably because earnings momentum is improving, with 2026E/2027E/2028E EPS raised to $5.11/$5.54/$6.13 from $4.86/$5.27/$5.91, reflecting stronger premium and fee performance. The outlook is supported by higher underwriting fee income assumptions of $11M in 4Q26E and $44M in both FY27E and FY28E, alongside a lower combined ratio in 2Q26 that drove results $0.13 above forecast. In addition, reduced interest expense estimates to $7M in 4Q26E and $29M/$30M in FY27E/FY28E indicate disciplined capital deployment toward debt repayment, strengthening profitability and financial flexibility.
Bears say
Skyward Specialty is viewed as having limited upside because its specialty focus, while strategically sound, is being introduced into a late-stage P&C market cycle where tailwinds may be fading. The company’s relatively new management strategy is acknowledged as a positive, but the fundamental concern is that the market backdrop reduces the likelihood of sustained multiple expansion or outsized growth from underwriting opportunities. As a result, the stock appears more exposed to cyclical normalization and less compelling on a forward risk-reward basis despite its niche positioning.
This aggregate rating is based on analysts' research of Skyward Specialty Insurance Group Inc and is not a guaranteed prediction by Public.com or investment advice.
SKWD Analyst Forecast & Price Prediction
Start investing in SKWD
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Skyward Specialty Insurance Group Inc (SKWD) Forecast
SKWD Analyst Forecast & Price Prediction
Start investing in SKWD
Order type
Buy in
Order amount
Est. shares
0 shares